2022 TaMADOR Meeting in Bethesda Mike MacCoss  2022-10-27 12:56:31
 

Multiplex quantification of protein/peptide hormones and biomarkers involved in obesity and diabetes will facilitate translational scientific research. The NIDDK recently funded several projects that aim to use targeted MS approaches for quantifying human plasma/serum proteins and peptides of main interest to the obesity and diabetes research community. This meeting will focus on advances by TArgeted Mass spectrometry Assays for Diabetes and Obesity Research (TAMADOR) consortium.

Register now: https://panoramaweb.org/TAMADOR/wiki-page.view?name=Bethesda-TaMADOR-Meeting